Sex difference in response to non-small cell lung cancer immunotherapy: an updated meta-analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Sex difference in response to non-small cell lung cancer immunotherapy: an updated meta-analysis

Published:2022-09-21 Issue:1 Volume:54 Page:2605-2615
ISSN:0785-3890
Container-title:Annals of Medicine
language:en
Short-container-title:Annals of Medicine

Author:

Liang Jiali¹,Hong Jiaze²,Tang Xin²,Qiu Xinyi¹,Zhu Keying²,Zhou Liyuan²,Guo Dina³

Affiliation:

1. The First School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China

2. The Second School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China

3. Department of Infectious Diseases, Ningbo Yinzhou No.2 Hospital, Ningbo, Zhejiang, China

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/07853890.2022.2124449

Reference44 articles.

1. Cancer and the Immune System: The History and Background of Immunotherapy

2. Sex differences in immune responses

3. The impact of sex and gender on immunotherapy outcomes

4. The sexist behaviour of immune checkpoint inhibitors in cancer therapy?

5. Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sex‐based immune microenvironmental feature heterogeneity in response to PD‐1 blockade in combination with chemotherapy for patients with untreated advanced non‐small‐cell lung cancer;Cancer Medicine;2024-06

2. Geschlechtsspezifische Aspekte beim Lungenkarzinom;Zeitschrift für Pneumologie;2024-04-23

3. Precision Immuno-Oncology in NSCLC through Gender Equity Lenses;Cancers;2024-04-04

4. Association Between Sex and Efficacy of Immune Checkpoint Inhibitors: A Systematic Review and Meta Analysis;Immunotherapy;2024-02-29

5. Lung cancer in females—sex-based differences from males in epidemiology, biology, and outcomes: a narrative review;Translational Lung Cancer Research;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3